MARCUS FOUNDATION GIVES $4,500,000 TO SUPPORT EMORY RESEARCH IN
The Marcus Foundation of Atlanta will give $4,500,000 over the next two years to establish the Marcus Chair in Vascular Medicine and the Marcus Vascular Research Fund in the Emory University School of Medicine.
"We are pleased to provide support for this important research, " commented Bernard Marcus, co-founder of Home Depot, who established the Marcus Foundation. "We look forward to timely advances in treatment of a number of life-threatening diseases and also to advances in wellness and disease prevention. The implications of successful discoveries in vascular health are significant and far-reaching. They will touch all our lives."
These two funds will be critical elements of the Center for Vascular
Diseases at Emory. The innovative research in blood vessel diseases
which they will fund is expected to have a major impact on many areas
of human health and wellness. Diseases of arteries are ultimately the
cause of death in at least half of all Americans. Diseases of large
arteries, with their inherent risk of clot formation and multiple small
strokes, are believed to cause more cases of dementia than does Alzheimer's
disease. In addition, scientists are increasingly theorizing that many
degenerative diseases and conditions ranging from Alzheimer's and Parkinson's
disease to heart failure and impotence are caused to an important extent
by diseases of the small blood vessels that ultimately deliver oxygen
and nutrients and remove waste from every organ.
"This wonderful gift will establish an outstanding partnership between
Emory and the Marcus Foundation," commented Michael M. E. Johns, M.D.,
Emory's executive vice president for health affairs and director of
the Robert W. Woodruff Health Sciences Center. "Mr. Marcus' vision encompasses
discoveries which could increase longevity and improve quality of life
for our present generation and for generations to come."
The Center for Vascular Diseases builds on existing strengths in vascular research at Emory, including research concerning the production of oxygen free radicals. These free radicals, produced inside blood vessel cells, stimulate mechanisms that attract inflammatory white cells, ultimately leading to disease and destruction of the artery. Other research initiatives are studying how to control cancer through reduction of the blood flow to cancer cells.
"The Center for Vascular Diseases will conduct further research to generate new understanding of the biology of blood vessel formation, regression and disease development," said Dr. Wayne Alexander, chairman of the Department of Medicine, Emory University School of Medicine.
Researchers also will work to develop new drugs and/or new uses for existing drugs or natural products that will treat and prevent vascular disease, and they will explore new strategies for growing blood vessels to treat obstructive arterial disease or, in the case of cancer, to inhibit new blood vessel growth, depriving cancer cells of needed nutrition.